Announcement on the Subsidiary Passing On-site Inspection by FDA

About this update from Zhejiang Huahai Pharmaceutical Co., Ltd. Class A

Announcement on the Subsidiary Passing On-site Inspection by FDAThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Huahai Pharmaceutical Co., Ltd. Class A